---
title: "Histamine - Leukemia, Myeloid, Acute"
sidebar: mydoc_sidebar
permalink: db05381-mesh-d015470-1.html
toc: false 
---


Path ID: `DB05381_MESH_D015470_1`
{% include image.html url="images/db05381-mesh-d015470-1.png" file="db05381-mesh-d015470-1.png" alt="db05381-mesh-d015470-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| <a href="https://identifiers.org/MESH:D006632">MESH:D006632 </a> | histamine | Drug |
| <a href="https://identifiers.org/UniProt:P60568">UniProt:P60568 </a> | Interleukin-2 | Protein |
| <a href="https://identifiers.org/UniProt:P01589">UniProt:P01589 </a> | Interleukin-2 receptor subunit alpha | Protein |
| <a href="https://identifiers.org/UniProt:P14784">UniProt:P14784 </a> | Interleukin-2 receptor subunit beta | Protein |
| <a href="https://identifiers.org/UniProt:P31785">UniProt:P31785 </a> | Cytokine receptor common subunit gamma | Protein |
| <a href="https://identifiers.org/reactome:R-HSA-9020558">reactome:R-HSA-9020558 </a> | Interleukin-2 signaling | Pathway |
| <a href="https://identifiers.org/GO:0045065">GO:0045065 </a> | cytotoxic T cell differentiation | BiologicalProcess |
| <a href="https://identifiers.org/GO:0030101">GO:0030101 </a> | natural killer cell activation | BiologicalProcess |
| <a href="https://identifiers.org/MESH:D015470">MESH:D015470 </a> | Leukemia, Myeloid, Acute | Disease |
|------------|------|---------|

## Relationships


NOTE: predicates are annotated in <a href="https://github.com/biolink/biolink-model/releases/tag/v1.3.0">Biolink Model (v1.3.0)</a>

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Histamine | INCREASES ACTIVITY OF | Interleukin-2 |
| Interleukin-2 | INCREASES ACTIVITY OF | Interleukin-2 Receptor Subunit Alpha |
| Interleukin-2 | INCREASES ACTIVITY OF | Interleukin-2 Receptor Subunit Beta |
| Interleukin-2 | INCREASES ACTIVITY OF | Cytokine Receptor Common Subunit Gamma |
| Interleukin-2 Receptor Subunit Alpha | POSITIVELY REGULATES | Interleukin-2 Signaling |
| Interleukin-2 Receptor Subunit Beta | POSITIVELY REGULATES | Interleukin-2 Signaling |
| Cytokine Receptor Common Subunit Gamma | POSITIVELY REGULATES | Interleukin-2 Signaling |
| Interleukin-2 Signaling | POSITIVELY REGULATES | Cytotoxic T Cell Differentiation |
| Interleukin-2 Signaling | POSITIVELY REGULATES | Natural Killer Cell Activation |
| Cytotoxic T Cell Differentiation | NEGATIVELY CORRELATED WITH | Leukemia, Myeloid, Acute |
| Natural Killer Cell Activation | NEGATIVELY CORRELATED WITH | Leukemia, Myeloid, Acute |
|---------|-----------|---------|

Comment: Histamine dihydrochloride that is used in Leukemia, Myeloid, Acute treatment.

Reference: 
  - [https://go.drugbank.com/drugs/DB05381#mechanism-of-action](https://go.drugbank.com/drugs/DB05381#mechanism-of-action)
  - [https://www.uniprot.org/uniprot/P60568#function](https://www.uniprot.org/uniprot/P60568#function)
  - [https://www.uniprot.org/uniprot/P01589#function](https://www.uniprot.org/uniprot/P01589#function)
  - [https://www.uniprot.org/uniprot/P14784#function](https://www.uniprot.org/uniprot/P14784#function)
  - [https://www.uniprot.org/uniprot/P31785#function](https://www.uniprot.org/uniprot/P31785#function)
  - [https://en.wikipedia.org/wiki/Histamine_dihydrochloride](https://en.wikipedia.org/wiki/Histamine_dihydrochloride)
  - [https://en.wikipedia.org/wiki/Acute_myeloid_leukemia](https://en.wikipedia.org/wiki/Acute_myeloid_leukemia)
